Medtronic
Medtronic Medtronic
Medtronic
Medtronic
Medtronic
Medtronic
Physician Information > Cardiovascular Surgery > Arrested Heart Surgery
> Adult Perfusion Circuit > T2T
 
 
 
 
 
 
Medtronic Indications, contraindications, warnings, precautions, and adverse events
 
 
 
Medtronic
Medtronic

Trillium® Biosurface**

Triple Endothelial-like Action for Biocompatibility

Trillium Biosurface

Trillium® Biosurface provides endothelial-like benefits for routine use during cardiopulmonary bypass procedures.

Heparin

  • Non-leaching heparin molecules are covalently bonded into the surface to provide anticoagulant and additional beneficial effects as heparan sulfate does in the natural endothelium.

Negative charge

  • Sulphate and sulfonate groups are incorporated into the Trillium® functional layer to mimic the negative charge of vascular endothelium.
  • Research demonstrates that negatively-charged sulphonated polymers:
    • Repel the negatively-charged platelets18,19,20
    • Inhibit thrombin by binding to antithrombin in a heparin-like manner21,22,23
    • May impair additional processes required for thrombus formation24,25
  • Heparin in Trillium® Biosurface is naturally negatively charged.

Hydrophilicity

  • Polyethylene oxide (PEO) polymer is extremely hydrophilic along its entire chain, creating an "insulating" water layer structure between the blood and artificial surface to resist cell adhesion and protein deposition.
    • PEO-water interface has very low free energy and therefore a low driving force for protein adsorption or platelet adhesion.26,27
    • PEO chains are in continuous motion, due to their flexible molecular structure. The dynamic hydrated surface created by PEO chains is believed to repel proteins and platelets.28,29
  • Hydrophilic priming layer is strongly bonded to the artificial surface.

Trillium coated
Trillium® coated

Uncoated
Uncoated

Scanning electron micrographs of oxygenator fiber surfaces after one hour of in vitro circulation in a closed system using heparinized, diluted human blood. (100X magnification)

Trillium® Biosurface peer-reviewed published clinical and scientific findings:*

  • Decreased likelihood to require blood products30
  • Platelet count preservation31,32,33,34,35
    • Affords the same protective effects on circulating platelet count drops as adding albumin to the prime32
  • Less platelet activation34
  • Less granulocyte activation34
  • Less complement activation after protamine administration33
  • Fewer circuit clots and no renal emboli35

* Select published articles

** Technology licensed under agreement from BioInteractions, Limited, United Kingdom.

Ask your Medtronic Representative today how T2T can benefit your patients.

Glossary Contact Medtronic Privacy Statement Terms of Use
Home About Medtronic